Related Experiment Videos
Carbon monoxide promotes hypoxic pulmonary vascular remodeling
Martha Sue Carraway1, Andrew J Ghio, Hagir B Suliman
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Summary
Carbon monoxide (CO) exposure exacerbates hypoxic pulmonary vascular remodeling in rats. This study found CO worsens pulmonary vascular resistance and vessel growth during high-altitude simulated hypoxia.
Area of Science:
- Physiology
- Cardiovascular Research
- Environmental Medicine
Background:
- Carbon monoxide (CO) is a biologically active gas with known cellular effects.
- CO binding to heme proteins increases under hypoxic conditions.
- Hypoxic pulmonary vascular remodeling is a significant physiological response.
Purpose of the Study:
- To investigate the hypothesis that CO interferes with hypoxic pulmonary vascular remodeling in vivo.
- To determine the effects of CO exposure on pulmonary vascular changes during hypobaric hypoxia (HH).
Main Methods:
- Rats were exposed to inspired CO (50 ppm) under normobaric and hypobaric hypoxic (HH) conditions.
- Vessel morphometry, pulmonary pressure-flow relationships, and vascular cell proliferation markers (ssDNA, PCNA) were assessed.
- Gene and protein expression of smooth muscle alpha-actin (sm-alpha-actin), beta-actin, and heme oxygenase-1 (HO-1) were evaluated.
Main Results:
- HH significantly increased pulmonary vascular pressure, vessel wall thickness, and pulmonary vascular resistance (PVR), while decreasing lumen diameter.
- CO exposure during HH further amplified PVR and increased the number of small muscular vessels.
- CO + HH elevated vascular PCNA and ssDNA, indicating accelerated cell turnover, and altered actin expression.
Conclusions:
- CO exposure in the context of hypobaric hypoxia promotes pulmonary vascular remodeling and increases PVR.
- CO appears to accelerate cellular turnover and modify gene expression in pulmonary arteries during hypoxia.
- These findings suggest a detrimental role for CO in exacerbating altitude-induced pulmonary vascular changes.